POCUS Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies

Led by University of Texas Southwestern Medical Center · Updated on 2026-04-07

N/A

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

This is a prospective, randomized control trial in which each patient will be randomly assigned to receive either extended half-life factor VIII based replacement therapy or non-FVIII based replacement therapy, which are both standard of care treatment for persons with Hemophilia A.

CONDITIONS

Brief Title

POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies

Who Can Participate

Age: 0 - 17Years

All Genders

Eligibility Criteria

Inclusion Criteria:

Subjects with moderate hemophilia A (baseline factor VIII activity 1-5%) or severe hemophilia A (baseline factor VIII activity <1%) on prophylactic standard half-life FVIII infusions OR subjects with moderate or severe hemophilia A who have not started prophylactic treatment
Less than 18 years of age

Exclusion Criteria:

Subjects with documented FVIII inhibitor
Subjects with a history of ≥ 2 target joints
Subjects with a history of synovectomy
Currently using medications known to impact bone and mineral metabolism (e.g., bisphosphonates, corticosteroids, estrogen, testosterone, calcitonin, thyroid hormone therapy);
Disease states known to affect bone integrity (e.g., primary hyperparathyroidism, Paget's disease, clinically significant liver disease)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

POCUS Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies

On this page

AI-Summary

What this Trial Is About

Brief Title

Who Can Participate

Eligibility Criteria

Not the Right Trial for You?

On this page

Who Can Participate

Eligibility Criteria